Yvette Matser

5PUBLICATIONS
47CO-AUTHORS
Predictive and prognostic markersMedical biochemistry - nucleic acidsMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 01, 2026
Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

|Mar 12, 2026
Effect of MYCN Amplification on Tumor Response and Recurrence in Patients With Stage IV Neuroblastoma.

Yvette A H Matser, André B P van Kuilenburg, Atia Samim

|Feb 21, 2025
Urinary Catecholamines Predict Relapse During Complete Remission in High-Risk Neuroblastoma.

Yvette A H Matser, Atia Samim, Marta Fiocco

|Apr 03, 2023
Optimising urinary catecholamine metabolite diagnostics for neuroblastoma.

Yvette A H Matser, Iedan R N Verly, Maria van der Ham

|Jan 27, 2022
Urinary 3-Methoxytyramine Is a Biomarker for MYC Activity in Patients With Neuroblastoma.

Iedan R N Verly, Yvette A H Matser, René Leen

Pageof 1

Frequent Collaborators

5 joint publications

Godelieve Tytgat

3 joint publications

André B P van Kuilenburg

3 joint publications

Karin P S Langenberg

2 joint publications

Iedan R N Verly